Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial

  1. Goss, P.E.
  2. Smith, I.E.
  3. O'Shaughnessy, J.
  4. Ejlertsen, B.
  5. Kaufmann, M.
  6. Boyle, F.
  7. Buzdar, A.U.
  8. Fumoleau, P.
  9. Gradishar, W.
  10. Martin, M.
  11. Moy, B.
  12. Piccart-Gebhart, M.
  13. Pritchard, K.I.
  14. Lindquist, D.
  15. Chavarri-Guerra, Y.
  16. Aktan, G.
  17. Rappold, E.
  18. Williams, L.S.
  19. Finkelstein, D.M.
Aldizkaria:
The Lancet Oncology

ISSN: 1470-2045 1474-5488

Argitalpen urtea: 2013

Alea: 14

Zenbakia: 1

Orrialdeak: 88-96

Mota: Artikulua

DOI: 10.1016/S1470-2045(12)70508-9 GOOGLE SCHOLAR